Skip to main content
. 2019 Dec 6;20(24):6155. doi: 10.3390/ijms20246155
AAI aristolochic acid I
AAN aristolochic acid nephropathy
BEN Balkan endemic nephropathy
BRCA breast cancer susceptibility gene
bw body weight
CDK cyclin-dependent kinase
CYP cytochrome P450
EMT epithelial-to-mesenchymal transition
FDR false discovery rate
GLUT glucose transporter
HIF-1 hypoxia-inducible factor 1
Hupki human TP53 knock-in
i.p. intraperitoneal
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells
NGAL or LCN2 neutrophil gelatinase-associated lipocalin
NQO NAD(P)H:quinone oxidoreductase
OAT organic anion transporter
p p-value
p21Cip1/Waf1 or CDKN1A cyclin-dependent kinase inhibitor 1a
p53 tumour protein p53
QC quality control
SLC solute carrier
TP53 tumour protein 53 gene (human)
Trp53 tumour protein 53 gene (mouse)